Companies & Industry »Company News»Company News Details
Company News Details

BSE   28 May 15 | 03:23 PM

1860.00 13.65 (0.74%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: 532321
Face Value: N.A.

NSE   28 May 15 | 03:14 PM

1865.90 11.6 (0.63%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: CADILAHC
Performance
1 Week : Rs 1,755.55 (5.95%)
1 Month : Rs 1,661.25 (11.96%)
1 Year : Rs 909.60 (104.49%)
change companytradenow
Back

Cadila's stock rising: Credit Suisse

Reuters / 18 Jul 12 | 11:50 AM

Credit Suisse initiates coverage on Cadila Healthcare with an "outperform" rating and a target price of Rs 970.

Investment bank says the midcap drug maker has demonstrated "strong execution" in the United States, with a portfolio mix focusing on low competition products such as nasal sprays and injectable drugs.

USFDA approval of its facilities in Moraiya, part of Gujarat, will re-start new approvals of its drugs in the US market, Credit Suisse adds.

"Cadila is moving up the value-chain with the launch of difficult-to formulate products and its strong execution record provides multi-year growth visibility."

Sensex

Company Price Gain (%)
Tata Motors483.952.61
Vedanta196.502.32
Hero Motocorp2,650.001.73
Infosys2,000.001.57
ITC321.201.09

Online Portfolio

You can create Online Portfolio here using the below button.